Arbutus Biopharma Corporation
SUBSTITUTED 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME

Last updated:

Abstract:

The present disclosure includes substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and compositions comprising the same, which can be used to treat and/or prevent hepatitis B virus (HBV) and/or hepatitis B virus (HBV)-hepatitis D virus (HDV) infection in a patient.

Status:
Application
Type:

Utility

Filling date:

14 May 2019

Issue date:

19 Aug 2021